Quick Summary

Sida cordifolia is a medicinal plant traditionally used in Ayurveda. It is currently being investigated in clinical research for conditions such as frozen shoulder and presbycusis (age-related hearing loss). While preclinical studies suggest potential pharmacological benefits, current clinical evidence on its efficacy in specific health conditions is limited and ongoing.

What is it?

Sida cordifolia, also known by its Latin name Sida cordifolia, is a plant commonly used in traditional Ayurvedic medicine. It is known for its potential therapeutic properties and is often included in various herbal formulations.

Traditional Uses

Traditionally, Sida cordifolia has been used in Ayurveda for various health purposes, including managing musculoskeletal and neurological conditions. It is often employed as part of herbal decoctions and topical preparations.

Active Compounds

Sida cordifolia contains several bioactive compounds, although specific constituent details require further elucidation. Historically, it has been noted to include alkaloids, flavonoids, and other phytochemicals common to Ayurvedic medicinal plants.

Potential Benefits with Evidence Levels

  • Frozen shoulder (adhesive capsulitis) — Research Pending: An ongoing randomized controlled trial is evaluating the efficacy of nasal administration of Sida cordifolia oil compared with honey thermal microcautery and standard physiotherapy. Results are expected in late 2025.
  • Presbycusis (age-related hearing loss) — Research Pending: An exploratory randomized controlled trial is underway investigating the use of a topical oil containing Sida cordifolia (Kshirabala Taila) for tinnitus suppression and hearing function protection. Results are pending.
  • Osteopenia/Osteoporosis — Insufficient Evidence Specific to Sida Cordifolia: A clinical study on Asthiposhak tablets, an Ayurvedic formulation, suggested benefits for bone mineral density, but direct evidence implicating Sida cordifolia alone is lacking.
  • Neuropathic or chemotherapy-induced peripheral neuropathy — Preclinical: Animal studies with herbal decoctions including combinations potentially involving Sida cordifolia showed efficacy. However, no direct clinical trials on Sida cordifolia alone are available.

Side Effects

No specific adverse effects of Sida cordifolia have been reported in human clinical trials to date. However, safety profiles remain to be fully established in completed and published studies.

Drug Interactions

No direct clinical evidence exists regarding drug interactions with Sida cordifolia. Limited pharmacological data suggest that it may affect drug-metabolizing enzymes commonly involved in herb-drug interactions. This theoretical potential warrants further investigation.

Who Should Avoid It?

No documented specific contraindications for Sida cordifolia have been identified in clinical literature. Nonetheless, caution is advised due to the absence of comprehensive safety data. Use during pregnancy or breastfeeding is not recommended as no safety data are available.

Evidence Limitations

  • Most clinical trials are currently underway, with no published results assessing efficacy or safety of Sida cordifolia alone.
  • Existing evidence is mainly from study protocols, preclinical, and animal research without completed human clinical trial outcomes.
  • Some studies have small sample sizes, lack blinding, and involve heterogeneous interventions, limiting generalizability.
  • Potential herb-drug interactions and long-term safety profiles remain under-researched.
  • No data are available on safety during pregnancy, breastfeeding, or long-term adverse effects.

References

Last Reviewed

June 2024

Disclaimer: This page is for informational purposes only and does not constitute medical advice. The efficacy and safety of Sida cordifolia require further research. Consult a qualified healthcare professional before starting any new herbal treatments or supplements, especially if you have existing medical conditions or are taking other medications.